*I'm not aware of any issues of decreased efficacy when stopping mesalamines and then restarting them at a later time.
*There are concerns with stopping and restarting biologics, but that has to do with increased risk of infusion reaction, allergic reaction, and/or antibody formation.
*Meta-analysis of multiple studies on chemopreventive ability of mesalamines shows a decrease in risk of colorectal cancer for UC patients. But that decrease is actually, statistically speaking, quite small - just above the level needed to be statistically significant. Edit to add: If you look at the various individual studies, some show mesalamines decrease the risk of colorectal cancer; some show no effect; and some show a little *higher* chance of colorectal cancer when taking mesalamines. Combining the data from all the studies shows a slightly decreased risk of colorectal cancer when taking mesalamines.
*There are some who hypothesize that any medication that reduces the inflammation of UC may have chemopreventive properties as well. It's too early to know with any of the biologics, but they may reduce the risks of colorectal cancer more than mesalamines. Or they may not.
*Lots of patients stop mesalamines when they go on biologics. Lots of patients stay on them too. No right or wrong answer. Rates of improvement/remission on biologics + mesalamines is probably just slightly better than rates of improvement/remission on biologics alone (I'm not aware of data that really compares this, so that's a guess).
Post Edited (beave) : 6/21/2017 10:11:40 PM (GMT-6)